SCS Capital Management LLC Makes New Investment in Ventas, Inc. $VTR

SCS Capital Management LLC acquired a new position in shares of Ventas, Inc. (NYSE:VTR) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 298,587 shares of the real estate investment trust’s stock, valued at approximately $26,648,000. SCS Capital Management LLC owned 0.06% of Ventas as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of VTR. Vanguard Group Inc. increased its stake in Ventas by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock valued at $5,876,856,000 after purchasing an additional 2,349,176 shares in the last quarter. State Street Corp raised its holdings in shares of Ventas by 2.5% during the fourth quarter. State Street Corp now owns 29,662,635 shares of the real estate investment trust’s stock valued at $2,309,234,000 after purchasing an additional 735,620 shares during the period. Geode Capital Management LLC boosted its position in shares of Ventas by 3.8% during the 4th quarter. Geode Capital Management LLC now owns 12,988,943 shares of the real estate investment trust’s stock worth $1,001,447,000 after purchasing an additional 475,633 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Ventas by 27.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 9,176,254 shares of the real estate investment trust’s stock worth $710,060,000 after purchasing an additional 2,000,341 shares in the last quarter. Finally, Capital World Investors bought a new position in shares of Ventas during the 4th quarter worth about $594,116,000. Institutional investors own 94.18% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently commented on VTR shares. Barclays initiated coverage on Ventas in a research report on Tuesday, July 7th. They issued an “equal weight” rating and a $99.00 target price for the company. JPMorgan Chase & Co. increased their price target on Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. Raymond James Financial initiated coverage on Ventas in a research note on Tuesday, June 16th. They issued an “outperform” rating and a $94.00 price objective for the company. Jefferies Financial Group raised their price objective on Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Finally, Royal Bank Of Canada boosted their price objective on Ventas from $98.00 to $99.00 and gave the company an “outperform” rating in a report on Friday. Fifteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Ventas presently has a consensus rating of “Moderate Buy” and a consensus price target of $98.00.

Ventas Stock Up 1.3%

VTR stock opened at $91.48 on Friday. The firm has a market capitalization of $46.92 billion, a PE ratio of 169.40, a P/E/G ratio of 2.11 and a beta of 0.69. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. Ventas, Inc. has a twelve month low of $66.38 and a twelve month high of $101.60. The stock’s 50 day moving average is $90.45 and its 200-day moving average is $86.54.

Insider Buying and Selling

In related news, Director Michael J. Embler acquired 2,500 shares of the company’s stock in a transaction on Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.53% of the company’s stock.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.